Ulipristal acetate versus gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Long term results of a double-blind randomized controlled trial

Autor: Judith A.F. Huirne, Marchien W. van Baal, Wouter J.K. Hehenkamp, Peggy M.A.J. Geomini, Inge de Milliano, Judith E. Bosmans, Benedictus C. Schoot, Janet Kwee, Mei An Middelkoop

Publikováno v: European Journal of Obstetrics and Gynecology and Reproductive Biology, 252, 256-264. Elsevier Ireland Ltd
De Milliano, I, Middelkoop, M A, Huirne, J A F, Kwee, J, Geomini, P M A J, Schoot, B C, Van Baal, M, Bosmans, J E & Hehenkamp, W J K 2020, ' Ulipristal acetate versus gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Long term results of a double-blind randomized controlled trial ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 252, pp. 256-264 . https://doi.org/10.1016/j.ejogrb.2020.06.035
De Milliano, I, Middelkoop, M A, Huirne, J A F, Kwee, J, Geomini, P M A J, Schoot, B C, Van Baal, M, Bosmans, J E & Hehenkamp, W J K 2020, ' Ulipristal acetate versus gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial) : Long term results of a double-blind randomized controlled trial ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 252, pp. 256-264 . https://doi.org/10.1016/j.ejogrb.2020.06.035

Objective: The aim of this study was to compare the effect of ulipristal acetate (UPA) and gonadotropin-releasing hormone agonists (GnRHa) before laparoscopic myomectomy on long term secondary outcomes of the MYOMEX-trial, regarding quality of life,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697315a3658720abb985bed2aad4c6e8
https://research.vu.nl/en/publications/2c891527-7c1a-4766-866b-6d986411d0d3

Cumulative live birth rates in low-prognosis women

Autor: Harold R. Verhoeve, Egbert A. Brinkhuis, Simone C Oudshoorn, Marcel H.A van Hooff, Joop S.E. Laven, G.J. Scheffer, Ben W.J. Mol, Jan Bruin, Annemiek W. Nap, Monique H. Mochtar, G. Jur E. Oosterhuis, Marinus J.C. Eijkemans, Ron J. T. van Golde, Theodora C. van Tilborg, Walter K. H. Kuchenbecker, Janet Kwee, Frank J.M. Broekmans, Kathrin Fleischer, Evert J.P. van Santbrink, A. Petra Manger, Annemieke Hoek, Carolien A.M. Koks, Cornelis B. Lambalk, Jori A Leijdekkers, Corry H. Dekoning, Jesper M. J. Smeenk, Madelon van Wely, Helen L. Torrance, Alexander V. Sluijmer, Bendictus C. Schoot, Jaap Friederich, Arie Verhoeff, Henk Groen

Publikováno v: Human reproduction (Oxford, England), 34(6):dez051, 1030-1041. Oxford University Press
Human Reproduction, 34(6), 1030-1041. Oxford University Press
Leijdekkers, J A, Eijkemans, M J C, van Tilborg, T C, Oudshoorn, S C, van Golde, R J T, Hoek, A, Lambalk, C B, de Bruin, J P, Fleischer, K, Mochtar, M H, Kuchenbecker, W K H, Laven, J S E, Mol, B W J, Torrance, H L, Broekmans, F J M, Koks, C A M, Verhoeve, H R, Nap, A W, Scheffer, G J, Manger, A P, Schoot, B C, Oosterhuis, G J E, Sluijmer, A V, Friederich, J, Verhoeff, A, van Hooff, M H A, van Santbrink, E J P, Brinkhuis, E A, Smeenk, J M J, Kwee, J, Dekoning, C H, Groen, H & van Wely, M 2019, ' Cumulative live birth rates in low-prognosis women ', Human Reproduction, vol. 34, no. 6, pp. 1030-1041 . https://doi.org/10.1093/humrep/dez051
Human Reproduction, 34, 1030-1041
Human Reproduction (Oxford, England)
Human Reproduction, 34, 6, pp. 1030-1041

STUDY QUESTION: Do cumulative live birth rates (CLBRs) over multiple IVF/ICSI cycles confirm the low prognosis in women stratified according to the POSEIDON criteria? SUMMARY ANSWER: The CLBR of low-prognosis women is ~56% over 18 months of IVF/ICSI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e8af2b6d2c4fdfb4db98c6904b6573a
https://doi.org/10.1093/humrep/dez051

Individualized versus standard FSH dosing in women starting IVF/ICSI

Autor: Marinus J.C. Eijkemans, Jaap Friederich, Janet Kwee, Marcel H.A van Hooff, Corry H. de Koning, Helen L. Torrance, Cornelis B. Lambalk, G. Jur E. Oosterhuis, Frank J.M. Broekmans, Henk Groen, Jesper M. J. Smeenk, Theodora C. van Tilborg, Ben W.J. Mol, Evert J.P. van Santbrink, Simone C Oudshoorn, Egbert A. Brinkhuis

Publikováno v: Human Reproduction, 32(12), 2506-2514. Oxford University Press
Oudshoorn, S C, van Tilborg, T C, Eijkemans, M J C, Oosterhuis, G J E, Friederich, J, van Hooff, M H A, van Santbrink, E J P, Brinkhuis, E A, Smeenk, J M J, Kwee, J, de Koning, C H, Groen, H, Lambalk, C B, Mol, B W J, Broekmans, F J M, Torrance, H L & OPTIMIST study group 2017, ' Individualized versus standard FSH dosing in women starting IVF/ICSI : an RCT. Part 2: The predicted hyper responder ', Human Reproduction, vol. 32, no. 12, pp. 2506-2514 . https://doi.org/10.1093/humrep/dex319

STUDY QUESTION: Does a reduced FSH dose in women with a predicted hyper response, apparent from a high antral follicle count (AFC), who are scheduled for IVF/ICSI lead to a different outcome with respect to cumulative live birth rate and safety?SUMMA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::838e636b602d43eb7995187715e445b0
https://doi.org/10.1093/humrep/dex319

Hysteroscopy before in-vitro fertilisation (inSIGHT): a multicentre, randomised controlled trial

Autor: Janet Kwee, G.J. Scheffer, Frank J. M. Broekmans, Carolien A.M. Koks, Annemiek W. Nap, Jenneke C. Kasius, Ramon H. M. Dykgraaf, Eugenie M. Kaaijk, Jaap Friederich, Benedictus C. Schoot, Annemieke Hoek, Femke Mol, Corry H. de Koning, Kathrin Fleischer, Helen L. Torrance, Arne M. van Heusden, Leonie A. Louwe, Ronald J T van Golde, Walter K. H. Kuchenbecker, Ineke C. A. H. Janssen, Alexander V. Sluijmer, Marinus J.C. Eijkemans, Janine G. Smit, Marcel H.A van Hooff, Ben W.J. Mol, Petra A. P. Manger, Denise A. M. Perquin

Publikováno v: Lancet (UK), 387(10038), 2622-2629. Elsevier Ltd.
The Lancet (London), 387, 2622-9
Lancet, 387(10038), 2622-2629. Elsevier Science
The Lancet, 387(10038), 2622. Elsevier Limited
Obstetrical & Gynecological Survey, 71(10), 600. Lippincott Williams and Wilkins
The Lancet, 387(10038), 2622-2629. ELSEVIER SCIENCE INC
Lancet, 387(10038), 2622-2629
The Lancet (London), 387, 10038, pp. 2622-9
Lancet, 387(10038), 2622-2629. Elsevier Limited

Since the first successful live birth after in vitro fertilization (IVF) was reported in 1978, more than 5 million children have been born with the help of this and intracytoplasmic sperm injection (ICSI) procedures. However, only approximately 25% t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef549ce24208b4c120c67ae84d14ed97
https://doi.org/10.1016/s0140-6736(16)00231-2

Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve

Autor: Roel Schats, Frank H. de Jong, Cornelis B. Lambalk, Axel P. N. Themmen, Janet Kwee, Joseph McDonnell

Publikováno v: Fertility & Sterility, 90(3), 737-743. Elsevier Inc.
Kwee, J, Schats, R, Mcdonnell, J, Themmen, A, de Jong, F & Lambalk, C B 2008, ' Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve ', Fertility and Sterility, vol. 90, no. 3, pp. 737-743 . https://doi.org/10.1016/j.fertnstert.2007.07.1293
Fertility and Sterility, 90(3), 737-743. Elsevier Inc.

Objective To compare in an integral way the value of the basal serum anti-Mullerian hormone (AMH) level with most of the established ovarian reserve tests. Design Prospective randomized controlled trial. Setting Fertility center of a university hospi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b224b518a10956c4947830bb7cf1f501
https://doi.org/10.1016/j.fertnstert.2007.07.1293